Leukemia & Lymphoma, 1029-2403

Journal

More filtering options
  1. 2021
  2. Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study

    Aldana Rosso, Gunnar Juliusson, Fryderyk Lorenz, Sören Lehmann, Åsa Derolf, Stefan Deneberg, Martin Jädersten, Petar Antunovic, Jörg Cammenga, Lars Möllgård, Lovisa Wennström, Emma Ölander, Mats Ehinger, Linda Fogelstrand, Martin Höglund & Vladimir Lj Lazarevic, 2021 Mar 10, In: Leukemia & Lymphoma. 9 p.

    Research output: Contribution to journalArticle

  3. 2020
  4. 2019
  5. Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

    Erik Delsing Malmberg, Sofie Johansson Alm, Malin Nicklasson, Vladimir Lazarevic, Sara Ståhlman, Tore Samuelsson, Stig Lenhoff, Julia Asp, Mats Ehinger, Lars Palmqvist, Mats Brune & Linda Fogelstrand, 2019, In: Leukemia and Lymphoma. 60, 2, p. 409-417

    Research output: Contribution to journalArticle

  6. 2018
  7. Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations

    Martin Dreyling, Igor Aurer, Sergio Cortelazzo, Olivier Hermine, Georg Hess, Mats Jerkeman, Steven Le Gouill, Vincent Ribrag, Marek Trněný, Carlo Visco, Jan Walewski, Francesco Zaja & Pier Luigi Zinzani, 2018, In: Leukemia and Lymphoma. 59, 8, p. 1814-1828

    Research output: Contribution to journalArticle

  8. 2017
  9. Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study

    Henrik Cederleuf, Lasse Hjort Jakobsen, Fredrik Ellin, Peter de Nully Brown, Thomas Stauffer Larsen, Martin Bøgsted, Thomas Relander, Mats Jerkeman & Tarec Christoffer El-Galaly, 2017 Dec 2, In: Leukemia and Lymphoma. 58, 12, p. 2815-2823 9 p.

    Research output: Contribution to journalArticle

  10. Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

    Muhammad Sharif Hasni, Mattias Berglund, Konstantin Yakimchuk, Jiyu Guan, Johan Linderoth, Rose-Marie Amini, Gunilla Enblad & Sam Okret, 2017 Feb 1, In: Leukemia & Lymphoma. 58, 2, p. 418-427 10 p.

    Research output: Contribution to journalArticle

  11. Frequency and clinical implications of SOX11 expression in Burkitt lymphoma

    Tove Wästerlid, Lena Nordström, Catja Freiburghaus, Mette Pedersen, Peter Nørgaard, Anne O. Gang, Peter Brown, Michael Dictor, Mats Jerkeman & Sara Ek, 2017, In: Leukemia & Lymphoma. 58, 7, p. 1760-1763 4 p.

    Research output: Contribution to journalLetter

  12. Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

    Georg Hess, Simon Rule, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, Isabelle Bence-Bruckler, Seok-Goo Cho, Wenjiong Zhou, Jenna D Goldberg, Cristina Trambitas, Christopher Enny, Jessica Vermeulen, Shana Traina, Chiun Fang Chiou, Joris Diels & Martin Dreyling, 2017, In: Leukemia and Lymphoma. 58, 12, p. 2824-2832

    Research output: Contribution to journalArticle

  13. Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia

    Elham Yektaei-Karin, Ana Zovko, Anders Nilsson, Barbro Näsman-Glaser, Lena Kanter, Olof Rådmark, Jonas Wallvik, Marja Ekblom, Monika Dolinska, Hong Qian & Leif Stenke, 2017, In: Leukemia & Lymphoma. 58, 8, p. 1903-1913 11 p.

    Research output: Contribution to journalArticle

  14. 2016
  15. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia

    Ingegerd Ivanov Öfverholm, Anh Nhi Tran, Linda Olsson, Vasilios Zachariadis, Mats Heyman, Eva Rudd, Elisabeth Syk Lundberg, Magnus Nordenskjöld, Bertil Johansson, Ann Nordgren & Gisela Barbany, 2016, In: Leukemia & Lymphoma. 57, 9, p. 2161-2170 10 p.

    Research output: Contribution to journalArticle

  16. Single nucleotide polymorphism array analysis of clonal evolution in younger adult acute lymphoblastic leukemia

    Vaidas Dirse, Egle Gineikiene, Tadas Zvirblis, Ruta Bertasiute, Kajsa Paulsson & Laimonas Griskevicius, 2016, In: Leukemia & Lymphoma. 57, 11, p. 2716-2719 4 p.

    Research output: Contribution to journalArticle

  17. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.

    Venera Kuci, Lena Nordström, Paolo Conrotto & Sara Ek, 2016, In: Leukemia & Lymphoma.

    Research output: Contribution to journalArticle

  18. 2015
  19. F-18-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

    Karen Juul Mylam, Lale Kostakoglu, Martin Hutchings, Morton Coleman, Dominick Lamonica, Myron S. Czuczman, Louis F. Diehl, Anne L. Nielsen, Paw Jensen, Annika Loft, Helle W. Hendel, Victor Iyer, Sirpa Leppa, Sirkku Jyrkkio, Harald Holte, Mikael Eriksson, Dorte Gillstrom, Per B. Hansen, Marko Seppanen, Karin Hjorthaug & 2 others, Peter de Nully Brown & Lars M. Pedersen, 2015, In: Leukemia & Lymphoma. 56, 7, p. 2005-2012

    Research output: Contribution to journalArticle

  20. Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries

    Virve Koljonen, Matti Rantanen, Helka Sahi, Lene Mellemkjaer, Bo Terning Hansen, Tianhui Chen, Kari Hemminki & Eero Pukkala, 2015, In: Leukemia & Lymphoma. 56, 12, p. 3315-3319

    Research output: Contribution to journalArticle

  21. Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

    Lotta Ohm, Adam Lundqvist, Paul Dickman, Martin Hoglund, Ulf Persson, Leif Stenke, Katarina Steen Carlsson & Magnus Bjorkholm, 2015, In: Leukemia & Lymphoma. 56, 5, p. 1385-1391

    Research output: Contribution to journalArticle

  22. Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network

    Martin Dreyling, Virginia Amador, Mary Callanan, Mats Jerkeman, Steven Le Goui, Christiane Pott, Simon Rule & Francesco Zaja, 2015, In: Leukemia & Lymphoma. 56, 4, p. 866-876

    Research output: Contribution to journalReview article

  23. 2014
  24. Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas

    Therese Högfeldt, Per Johnsson, Dan Grandér, Abeer A. Bahnassy, Anna Porwit, Salem Eid, Anders Österborg, Abdel Rahman N. Zekri, Joachim Lundahl, Mustafa Hussein Khaled, Håkan Mellstedt & Ali Moshfegh, 2014 Jan 1, In: Leukemia and Lymphoma. 55, 5, p. 1158-1165

    Research output: Contribution to journalArticle

  25. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic

    Stephen P. Mulligan, Karin Karlsson, Mats Stromberg, Viggo Jonsson, Devinder Gill, Jens Hammerstrom, Mark Hertzberg, Roger McLennan, Bertil Uggla, John Norman, Jonas Wallvik, Gunnel Sundstrom, Hemming Johansson, Yvonne Brandberg, Jan Liliemark & Gunnar Juliusson, 2014, In: Leukemia & Lymphoma. 55, 12, p. 2769-2777

    Research output: Contribution to journalArticle

  26. 2013
  27. Protein kinase C expression is deregulated in chronic lymphocytic leukemia

    Nuzhat N. Kabir, Lars Rönnstrand & Julhash U. Kazi, 2013, In: Leukemia & Lymphoma. 54, 10, p. 2288-2290

    Research output: Contribution to journalLetter

  28. 2012
  29. Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

    Maciej Machaczka, Jan-Erik Johansson, Mats Remberger, Helene Hallbook, Claes Malm, Vladimir Lazarevic, Anders Wahlin, Hamdy Omar, Gunnar Juliusson, Eva Kimby & Hans Hagglund, 2012, In: Leukemia & Lymphoma. 53, 9, p. 1699-1705

    Research output: Contribution to journalArticle

  30. Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma

    Karin Fjordén, Patrick Joost, Mats Ehinger, Patrik Edén, Mats Jerkeman, Eva Cavallin-Ståhl & Johan Linderoth, 2012, In: Leukemia & Lymphoma. 53, 9, p. 1764-1768

    Research output: Contribution to journalArticle

  31. Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study

    Vladimir Lazarevic, Mats Remberger, Hans Hagglund, Gunnar Juliusson, Hamdy Omar, Helene Halbook, Eva Kimby, Claes Malm, Anders Wahlin & Jan-Erik Johansson, 2012, In: Leukemia & Lymphoma. 53, 3, p. 503-505

    Research output: Contribution to journalLetter

  32. MyelomA Genetics International Consortium

    Gareth Morgan, Hans Erik Johnsen, Hartmut Goldschmidt, Antonio Palumbo, Michele Cavo, Pieter Sonneveld, Jesus San Miguel, Char Sang Chim, Paul Browne, Hermann Einsele, Anders Waage, Ingemar Turesson, Andrew Spencer, Roman Hajek, Heinz Ludwig, Kari Hemminki & Richard Houlston, 2012, In: Leukemia & Lymphoma. 53, 5, p. 796-800

    Research output: Contribution to journalReview article

  33. 2011
  34. Hairy cell leukemia: epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy.

    Gunnar Juliusson & Henrik Samuelsson, 2011, In: Leukemia & Lymphoma. 52 Suppl 2, p. 46-49

    Research output: Contribution to journalArticle

  35. 'Hairy' cells: where are the roots of this leukemia?

    Gunnar Juliusson, Tamar Tadmor & Aaron Polliack, 2011, In: Leukemia & Lymphoma. 52, p. 2205-2206

    Research output: Contribution to journalArticle

  36. Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.

    Vladimir Lj Lazarevic, Hans H X00e4 Gglund, Mats Remberger, Anders Wahlin, Helene Hallb X00f6 X00f6 K, Gunnar Juliusson, Eva Kimby, Claes Malm, Hamdy Omar & Jan-Erik Johansson, 2011, In: Leukemia & Lymphoma. 52, p. 69-71

    Research output: Contribution to journalArticle

  37. Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry.

    Anna Abrahamsson, Nina Dahle & Mats Jerkeman, 2011, In: Leukemia & Lymphoma. 52, 10, p. 1929-1935

    Research output: Contribution to journalArticle

  38. Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.

    Tove Wästerlid, Björn Jonsson, Hans Hagberg & Mats Jerkeman, 2011, In: Leukemia & Lymphoma. 52, 11, p. 2090-2096

    Research output: Contribution to journalArticle

  39. The association of cancer and venous thrombosis: yes, Trousseau is right ... again!

    Sigurdur Yngvi Kristinsson & Ingemar Turesson, 2011, In: Leukemia & Lymphoma. 52, 5, p. 734-735

    Research output: Contribution to journalDebate/Note/Editorial

  40. 2010
  41. CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

    Karin Fjordén, Johan Linderoth, Heidi Nyman, Mats Ehinger, Patrick Joost, Pär-Ola Bendahl, Sirpa Leppä & Mats Jerkeman, 2010, In: Leukemia & Lymphoma. 51, p. 1643-1648

    Research output: Contribution to journalArticle

  42. 2009
  43. Clonal evolution to histiocytic sarcoma with the BCR/ABL rearrangement 14 years after acute lymphoblastic leukemia.

    Michael Dictor, Janina Warenholt, Czabafy Gyorgy, Ingrid Månsson & Gun Larsson, 2009, In: Leukemia & Lymphoma. 50, p. 1892-1895

    Research output: Contribution to journalLetter

  44. Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention.

    Claudia Stolz & Martin Schuler, 2009, In: Leukemia & Lymphoma. 50, p. 873-885

    Research output: Contribution to journalArticle

  45. 2008
  46. Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia

    Vladimir Lj Lazarevic, Maria Liljeholm, Karin Forsberg, Stefan Söderberg & Anders Wahlin, 2008 Jun, In: Leukemia & Lymphoma. 49, 6, p. 1209-11 3 p.

    Research output: Contribution to journalArticle

  47. Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group

    Eva Kimby, Jesper Jurlander, Christian Geisler, Hans Hagberg, Harald Holte, Tuula Lehtinen, Björn Östenstad, Mads Hansen, Anders Österborg, Ola Lindén & Christer Sundström, 2008, In: Leukemia & Lymphoma. 49, 1, p. 102-112

    Research output: Contribution to journalArticle

  48. 2007
  49. CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.

    Johan Linderoth, Mats Ehinger, Mats Jerkeman, Pär-Ola Bendahl, Måns Åkerman, Mattias Berglund, Gunilla Enblad, Martin Erlanson, Goran Roos & Eva Cavallin-Ståhl, 2007, In: Leukemia & Lymphoma. 48, 9, p. 1774-1779

    Research output: Contribution to journalArticle

  50. Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

    Mattias Berglund, Ulf Thunberg, Marie Fridberg, Anette Gjörloff Wingren, Joachim Gullbo, Karl-Johan Leuchowius, Rose-Marie Amini, Svetlana Lagercrantz, Andrea Biloglav, Gunilla Enblad & Ola Soderberg, 2007, In: Leukemia & Lymphoma. 48, 5, p. 1038-1041

    Research output: Contribution to journalLetter

  51. Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: Higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN

    Marie Fridberg, Anna Servin, Lola Anagnostaki, Johan Linderoth, Mattias Berglund, Ola Soderberg, Gunilla Enblad, Anders Rosen, Tomas Mustelin, Mats Jerkeman, Jenny L Persson & Anette Gjörloff Wingren, 2007, In: Leukemia & Lymphoma. 48, 11, p. 2221-2232

    Research output: Contribution to journalArticle

  52. 2006
  53. Chronic lymphocytic leukemia with osteolytic Richter's syndrome mimicking myeloma bone disease shows no over-expression of DKK1

    VLADIMIR LAZAREVIC, Anders Wahlin, Fenguang Zhan & John Shaughnessy, 2006 Sep, In: Leukemia & Lymphoma. 47, 9, p. 1987-8 2 p.

    Research output: Contribution to journalArticle

  54. Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy plus G-CSF in patients with chronic myelogenous leukemia in first chronic phase

    Ulla Olsson-Stromberg, Martin Hoglund, Magnus Bjorkholm, Inger Braide, Karin Carlson, Gosta Gahrton, Gunnar Grimfors, Robert Hast, Rickard Lerner, Olle Linder, Per Ljungman, Eva Lofvenberg, Claes Malm, Per-Gunnar Nilsson, Christer Paul, Stig Rodjer, Leif Stenke, Ulf Tidefeldt, Ingemar Turesson, Ann-Marie Uden & 6 others, Anders Wahlin, Lars Vilen, Ingemar Winqvist, Olle Zettervall, Gunnar Oberg & Bengt Simonsson, 2006, In: Leukemia & Lymphoma. 47, 9, p. 1768-1773

    Research output: Contribution to journalArticle

  55. 2002
  56. Exposure to pesticides as risk factor for Non-Hodgkin's lymphoma and hairy cell leukemia: Pooled analysis of two Swedish case-control studies

    Lennart Hardell, Mikael Eriksson & Marie Nordström, 2002, In: Leukemia and Lymphoma. 43, 5, p. 1043-1049

    Research output: Contribution to journalArticle

  57. 2001
  58. Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma

    L. Hardell, M. Eriksson, G. Lindström, B. Van Bavel, A. Linde, M. Carlberg & G. Liljegren, 2001 Jan 1, In: Leukemia and Lymphoma. 42, 4, p. 619-629

    Research output: Contribution to journalArticle